News

Amicus Therapeutics CEO to Speak at J.P. Morgan Conference 2025

Amicus Therapeutics CEO to Speak at J.P. Morgan Conference 2025

Amicus Therapeutics Announcement at Healthcare Conference

Amicus Therapeutics is excited to announce that Bradley Campbell, the President and Chief Executive Officer, will be presenting at the upcoming 43rd Annual J.P. Morgan Healthcare Conference. This notable event is set to take place in San Francisco, where leaders in the healthcare industry gather to share insights and advancements.

Event Details and Presentation Schedule

The presentation is scheduled for January 13, 2025, at 3:00 p.m. PT. This gathering serves as a vital platform for many companies to showcase their innovations and strategies, allowing investors and stakeholders to engage with the latest in biotechnology and healthcare.

Live Audio Webcast Access

To ensure that interested parties can attend the presentation remotely, Amicus Therapeutics will provide a live audio webcast of the event. Access to the webcast will be available through the investors section of their corporate website. This initiative reflects the company’s commitment to transparency and investor engagement.

About Amicus Therapeutics

Amicus Therapeutics is a patient-centric biotechnology company dedicated to developing high-quality therapies aimed at addressing unmet medical needs for rare diseases. The company emphasizes a strong connection with patients, ensuring that their research and development efforts are directly aligned with the needs of those they serve.

Pioneering Treatments for Rare Diseases

The organization is known for its cutting-edge approach in developing novel therapies. Amicus Therapeutics is continually advancing its pipeline of best-in-class medicines that open new possibilities for individuals facing rare diseases. As the landscape of healthcare evolves, Amicus stands out for its ingenuity and dedication to improving patient outcomes.

Commitment to Innovation

As part of its mission, Amicus Therapeutics is focused on innovating new treatments, thus enhancing patient quality of life. The company operates with a clear vision to bring forth therapies that are both effective and accessible to those in need.

Contact Information for Inquiries

For those looking for more information or needing to connect with Amicus Therapeutics:

Investor Relations Contact

Andrew Faughnan, Vice President of Investor Relations, is available for inquiries. Interested parties can reach out via email or phone to discuss investment opportunities and corporate updates.

Media Relations Contact

Diana Moore, Head of Global Corporate Affairs and Communications, can address media inquiries and provide insights into company developments. Communication channels are open to foster relationships with stakeholders and the public.

Frequently Asked Questions

What is the J.P. Morgan Healthcare Conference?

The J.P. Morgan Healthcare Conference is an annual event that gathers industry leaders to discuss advancements in healthcare and biotechnology.

How can I access the Amicus Therapeutics presentation?

The presentation can be accessed via a live audio webcast through the Amicus Therapeutics corporate website.

Who is presenting for Amicus Therapeutics?

Bradley Campbell, the President and CEO, will be the presenter at the event.

What does Amicus Therapeutics focus on?

Amicus Therapeutics is dedicated to developing therapies for rare diseases, emphasizing patient-centered innovation.

How can I contact Amicus Therapeutics for more information?

Contact can be made through their investor relations or media relations departments for any inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

METLEN Posts Record 9-Month Revenue in 2026

Updated Category News Views 85

Record Revenue Achievement Oh boy, METLEN just broke the bank with its nine-month trading update for 2026, hitting €6.2 billion in revenue. It's the highest they've ever seen for this period. A 21% jump from the previous €5.1 billion in 9M2025—now that's saying something in these unpredictable markets. Drilling down, the company’s business units showed they can...

Continue Reading
S&P 500 Drop: A Market Glitch or Future Trend?

Updated Category News Views 17

A Sudden Jolt in a Trending Market Mornings like these make you question your coffee strength. A major market dip, with the S&P 500 shedding 3.51%, is like a slap to the face, especially when the Nasdaq Composite takes a 5.24% nosedive. The Dow isn't spared, dropping 2.45%. But, let's not lose our heads here. Today is a blip, a pixel in the bigger picture where the S&P...

Continue Reading
Workday: Dominating Cloud ERP with AI Prowess in 2026

Updated Category News Views 11

Workday: A Force in the Cloud ERP Arena Right on! Workday's making waves again in the world of Cloud ERP. In a move that seems to defy the competition, they've locked down their spot as a Leader in the 2026 Gartner Magic Quadrant for Cloud ERP for Service-Centric Enterprises for the fifth year running. Consistency isn’t a coincidence here, folks—this is pure strategy!...

Continue Reading
Midterm Election Insights: Border Enforcement Debate Heats Up

Updated Category News Views 139

The Midterm Aftermath: What Really Matters So the ballots are counted, and once again, the shiny chatter about midterms seemed to orbit more around wallet aches and foreign skirmishes than dusty border control debates. But, dig a bit deeper—like poking at a sore spot—and you'll find border security sitting patiently in the wings. Not gone, just waiting for its...

Continue Reading
JT Mega Embraces New Leadership as Erin Denham Steps Up

Updated Category News Views 48

A New Captain at the Helm Erin Denham's promotion to president of JT Mega is setting the stage for some fresh momentum in the food and beverage advertising world. This Minnesotan agency, nestled right there on Minnetonka Boulevard, has been an independent force for five decades. It's a sector dominated by players who often get absorbed by the behemoth holding companies,...

Continue Reading
Breeze Airways Secures $228M for Fleet Expansion

Updated Category News Views 58

Breeze Airways and AIP's Milestone Deal Just as the ink is drying on the balance sheets, Breeze Airways is busy making significant moves in the aviation game. Partnering with AIP Capital, they just locked in a $228 million secured debt facility to grab six new Airbus A220-300 aircraft. Now, that’s how you stake your claim in the market. What we’ve got here isn’t...

Continue Reading
Qfin Holdings Faces Class Action Over Stock Drop

Updated Category News Views 122

Qfin Holdings' Troubled Waters Look, when a stock tanks by nearly 19% overnight, it isn't because of some fluke. And that's precisely what's got Qfin Holdings, Inc. investors gritting their teeth and lawyers sharpening their pencils. Deep Dive into Allegations For those keeping score, we're talking about serious allegations here: between March 18, 2026, and August 25,...

Continue Reading
Plasma Proteomics May Predict Immunotherapy Resistance

Updated Category News Views 46

Sifting Through Proteins: A Step Toward Precision Medicine In the world of lung cancer, the stakes are high, and any breakthrough is a glimmer of hope. OncoHost turned heads with their new research presented at the ISLB 2026, showing plasma proteomics' potential in detecting immunotherapy resistance for advanced non-small cell lung cancer (NSCLC). It's not just another...

Continue Reading
GaNrich: Gallium Nitride Game-Changer Expands Global Reach

Updated Category News Views 113

Rattling the Silicon Cage: GaNrich's Transformative Climb Well, folks, here's a story that makes even the most stoic traders sit up and take notice: GaNrich Semiconductor, a Taiwan-based trailblazer, is serving a wallop to the traditional silicon power device monopoly. By expanding their GaN power device portfolio to cover voltages ranging a whopping 40V to 1200V, GaNrich...

Continue Reading
GoldMining Ramps Up São Jorge Environmental Work

Updated Category News Views 73

GoldMining's Next Big Step in Brazil GoldMining Inc. is rolling up its sleeves in Brazil, diving headfirst into environmental and socioeconomic baseline studies pivotal for the São Jorge Gold Project. Right here, folks, we're seeing the groundwork for what could be a major leap forward. Anyone keeping an eye on TSX:GLDG might be sniffing what's cooking, especially when...

Continue Reading

Top 5 Most Recently Viewed Articles

Alys Pharmaceuticals' Groundbreaking Submission for ALY-301 Trial

Updated Category News Views 218

Alys Pharmaceuticals' CTA Submission for ALY-301 Study Alys Pharmaceuticals, Inc. has made an exciting announcement regarding its Clinical Trial Application (CTA) for ALY-301, a pioneering mast cell selective c-Kit inhibitor designed to treat Cold Urticaria. This represents a major advancement in immune-dermatology, showcasing Alys' commitment to developing targeted...

Continue Reading
Ensurge Micropower ASA's Upcoming Financial Opportunities

Updated Category News Views 50

Exploring Ensurge Micropower ASA’s Financial Strategies Ensurge Micropower ASA, a significant player in advanced battery technology, has recently made headlines with its strategic financial plans designed to enhance its capital resources. The company has unveiled a private share placement aiming to secure NOK 75 million, signaling a proactive stance toward financing its...

Continue Reading
Revamped iScanner App Unveils Cutting-Edge Document Repair Feature

Updated Category News Views 201

Introducing the New iScanner Edge Repair Feature Small business owners and remote workers often face challenges when it comes to scanning documents that are stapled or have uneven edges. Thankfully, the iScanner app offers a remarkable AI solution designed to ensure that every scan is perfect, regardless of the original document's condition. What is Edge Repair? The...

Continue Reading
Sprott Physical Uranium Trust Secures $200 Million in Funding

Updated Category News Views 262

Sprott Physical Uranium Trust Completes Major Financing Sprott Inc. recently announced the successful closure of an upsized bought deal public offering for the Sprott Physical Uranium Trust. This significant financial step involved issuing 11,600,000 units at a price of $17.25 per unit, resulting in total gross proceeds of approximately $200 million. Canaccord Genuity...

Continue Reading
The MATTIE Fund's Transformative Grants Empower Women's Health

Updated Category News Views 408

The MATTIE Fund's New Grants Highlight Commitment to Women The MATTIE Fund proudly unveils its first round of grants, totaling $1.5 million, aimed at empowering organizations dedicated to supporting women's mental health, emotional resilience, and overall well-being. This initiative is a significant step toward addressing the needs of diverse and marginalized women and...

Continue Reading